Many Women Bypass Nearest Hospital for Breast Cancer Surgery
By Elana Gotkine HealthDay Reporter
MONDAY, Jan. 8, 2024 -- Many women undergoing breast-conserving surgery (BCS) or mastectomy bypass their nearest hospitals, according to a study published online Jan. 8 in Cancer.
Ajay Aggarwal, M.D., Ph.D., from the London School of Hygiene and Tropical Medicine, and colleagues used linked administrative datasets from the English National Health Service to identify all women who underwent BCS or mastectomy with or without immediate breast reconstruction. A geographic information system was used to examine the extent to which patients bypassed their nearest hospital.
The researchers found that 32.7 percent of the 69,153 patients undergoing BCS and 30.5 percent of the 23,536 patients undergoing mastectomy bypassed their nearest hospital. The likelihood of traveling to more distant hospitals was increased for women who were younger, who had no comorbidities, and were from rural areas. Despite not undergoing reconstruction, women undergoing BCS or mastectomy were more likely to be treated at specialist breast reconstruction centers (odds ratios, 1.85 and 1.52, respectively). The likelihood of traveling to hospitals employing surgeons who had a media reputation was increased for patients receiving mastectomy and immediate breast reconstruction (odds ratio, 2.41). The likelihood of traveling to hospitals with shorter waiting time was lower for patients undergoing BCS (odds ratio, 0.65).
"Patients seem to be influenced by the reputation of hospitals and their surgeons, particularly those performing advanced breastâreconstruction techniques," the authors write. "This highlights that policies offering patients with breast cancer the opportunity to choose where they have their treatment may drive inequalities in the health care system without necessarily improving patient outcomes."
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer
TUESDAY, July 2, 2024 -- For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant...
Few Patients With Positive Margins After Basal Cell Excision Have Recurrence
MONDAY, July 1, 2024 -- Among patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic margins have clinical recurrence...
NCCN: Cancer Drug Shortages Remain a Challenge for Clinicians
FRIDAY, June 28, 2024 -- Almost 90 percent of medical centers report cancer drug shortages, which often impact clinical trials, according to the results of a National...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.